Home Analyst Ratings Jefferies upgrades Medifast to Buy rating with a $265 price target

Jefferies upgrades Medifast [MED] to Buy rating with a $265 price target

Jefferies took its Medifast [MED] rating to the equivalent of Buy from Hold, and the price target to $265.0 from $205, in a research note dated 2021-01-25. That figure represents around a 19.91% premium from where the company’s shares closed on Friday. Some new analysts also started their coverage, with B. Riley FBR’s analysts assigning the shares to “a Buy” rating in a research note to investors issued in late June. Meanwhile, Jefferies had lowered its rating on MED to “Hold” from the earlier “Buy”, in a research note produced for clients on February 27, 2020. In addition, there was a downgrade from Dougherty & Company on November 08, 2019. The rater changed MED from “a Buy” to “a Neutral”.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Is Medifast Inc. [NYSE: MED] a Good Buy Right Now?

It should be noted that MED technical indicators for short, intermediate as well as long term progress have placed an overall average of 100% as Buy. The average signal changed from 100% Buy in the last week and compares with 88% Buy in the past month. Data from Medifast Inc.’s Trend Spotter indicated that the signals were Weakest. The stock current average is 0.13 million shares in the past 20 days and the short term average signal indicates a 100% Buy. In the last 50 days, the average trading volume was 0.13 million shares while the medium-term average advocated for 100% Buy. The average long-term signal stands at 100% Buy and the 100-day average volume stands at 0.16 million shares.


The 2021 Backdoor Crypto Portfolio (free)

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.

Sponsored


MED Price Performance

On Wall Street, Medifast Inc. [NYSE:MED] finished Friday’s session down -0.20% at $220.87. The stock went up to $221.48 at the same session while its lowest single-day price was $217.5462. In the last five days, it saw a rise of about 2.35%, Medifast Inc. shares gained by almost 12.49% since the beginning of the year. However, the share price has dropped to as low as -3.55% below its one year high. On 01/20/21, the company shares recorded $229.00, the highest single-day price it has got to in the last 52-weeks, and a 52-week low was seen on 01/04/21, the same year at $190.69. The company’s shares have inclined by 102.69% in the past year. The 50-day SMA achieved is $197.38 while the 200-day SMA is $151.53. Volume gained to 87245.0 from 81900.0 in the previous session.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Apple Inc. (AAPL) Stocks dip but future prospects for the company seem very positive

On Thursday, Apple shares (NASDAQ: AAPL) closed at $120.99 which is 3.5% lower. In the after-hours session, the price further declined by 0.2%.  The...

Tesla Inc. (TSLA): a Game of Thrones, Tweets and Bitcoin

Tesla Inc. (NASDAQ: TSLA) shares plunged by more than 8% when the market closed on Thursday. The news that most significantly impacted this plunge...

The Reasons Behind 30% Fall Of Tricida, Inc.’s (TCDA) Shares In Extended Trades

The drugmaker Tricida, Inc.’s (TCDA) shares experienced a fall of -29.62% in the trading after the ring of the bell on Thursday. The South...

Why Chromadex Corp. (CDXC) Remains A Gainer After Ring Of The Bell?

The biotechnology company ChromaDex Corporation (CDXC) continued the rally after ring of the bell on Thursday rising +18.68%. During the regular session price of...

ReTo Eco-Solutions Stock Drops Pre-Market Today: Why?

The manufacturer and distributor of construction material ReTo Eco-Solutions Inc. (NASDAQ: RETO) has been experiencing a fall of more than 10% in pre-market session...

What Caused Amneal Pharmaceuticals (AMRX) To Rise 4% After-Hours On Friday? – Here Is An Explanation

Shares of fully integrated pharmaceutical company Amneal Pharmaceuticals Inc (AMRX) raised +3.9% on Friday after ring of the bell. The new came on the...

Why Atlas Crest Investment (ACIC) Stock Has Risen 9% After-Hour On Friday?

Atlas Crest Investment Corporation (NYSE: ACIC) stock came rising +8.91 to $12.96 in after-hour trading on Friday. The company saw its price falling -2.14%...

Were You Wondering Why Northern Dynasty (NAK) Stock Spiked 24% In Early Trades Today?

Shares of mineral exploration firm Northern Dynasty Minerals Ltd. (NYSE: NAK) has been gaining momentum in early trades today. As of 11:42 a.m. EST,...

Related News

KeyBanc reiterates Magna International [MGA] rating to Overweight and sets new price target at $86

KeyBanc maintained its Magna International rating to the equivalent of Overweight but changed the price target to $86.0 from $72, in a research...

American Eagle Outfitters [AEO] Upgraded to Outperform at RBC Capital

RBC Capital took its American Eagle Outfitters rating to the equivalent of Outperform from Sector Perform, and the price target to $30.0 from...

KeyBanc reiterates Nike [NKE] rating to Overweight and sets new price target at $180

KeyBanc maintained its Nike rating to the equivalent of Overweight but changed the price target to $180.0 from $174, in a research note...

Raymond James upgrades Atlantic Capital [ACBI] to Outperform

Raymond James took its Atlantic Capital rating to the equivalent of Outperform from Market Perform, in a research note dated 2021-01-25. Other analysts...

Tapestry [TPR] Stock Gets Reiterated At KeyBanc. It’s Still Overweight

KeyBanc maintained its Tapestry rating to the equivalent of Overweight but changed the price target to $38.0 from $35, in a research note...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!...100% Free

We do not sell or share your information with anyone.

Get Best Morning Financial Newsletter... 100% Free

Best stocks ideas

Analysts’ Upgrades & Downgrades

Insider Watchlist

Important Earnings

We do not sell or share your information with anyone.